NCT01691261View on ClinicalTrials.gov

A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degeneration

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 14, 2021

Primary Completion Date

October 10, 2023

Study Completion Date

June 24, 2024

Conditions
Age Related Macular Degeneration
Interventions
BIOLOGICAL

PF-05206388

PF-05206388 will be provided as a Retinal Pigment Epithelium living tissue equivalent for intraocular use in the form of a monolayer of Retinal Pigmented Epithelial (RPE) cells immobilized on a polyester membrane. The membrane is approximately 6 mm x 3 mm and will contain a confluent layer of RPE cells, at a nominal dose of 17 mm2. The implant is intended to be life-long.

Trial Locations (1)

EC1V 2PD

Moorfields Eye Hospital NHS Foundation Trust, London

All Listed Sponsors
collaborator

University College, London

OTHER

lead

Moorfields Eye Hospital NHS Foundation Trust

OTHER

NCT01691261 - A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degeneration | Biotech Hunter | Biotech Hunter